Stocktoria
enGene Therapeutics Inc. ENGN
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-12-10
enGene Therapeutics Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,035,627 | $1.7M | 1.99% |
| RENAISSANCE TECHNOLOGIES LLC | 829,700 | $1.4M | 1.6% |
| CITADEL ADVISORS LLC | 781,286 | $1.4M | 1.5% |
| TWO SIGMA INVESTMENTS, LP | 164,570 | $284,706 | 0.32% |
| D. E. Shaw & Co., Inc. | 104,622 | $30,330 | 0.2% |
| Point72 Asset Management, L.P. | 13,992 | $24,206 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.